SCHEMBL19081644

SCHEMBL19081644

c1ccc2c(-c3c4ccccc4c(-c4ccc(-c5ccc6oc7c(ccc8c7oc7ccc9ccccc9c78)c6c5)c5ccccc45)c4ccccc34)cccc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.40
MAPT P10636 4/20 0.36
HSD17B10 Q99714 4/20 0.36
ALDH1A1 P00352 3/20 0.36
HPGD P15428 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
TDP1 Q9NUW8 3/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
AHR P35869 3/20 0.36
CYP1A2 P05177 2/20 0.36
PAX8 Q06710 2/20 0.36
CYP1A1 P04798 1/20 0.36
FYN P06241 1/20 0.36
MAPK3 P27361 1/20 0.36
ABCG2 Q9UNQ0 1/20 0.36
KDM4E B2RXH2 3/20 0.36
RAB9A P51151 2/20 0.36
CYP2C19 P33261 2/20 0.36
NPC1 O15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081443 0.94 ALOX5 (0.39) ALOX5MAPTHSD17B10ALDH1A1HPGD
SCHEMBL19081609 0.92 ABCG2 (0.40) ALOX5MAPTHSD17B10ALDH1A1HPGD
SCHEMBL19081638 0.92 ALOX5 (0.37) ALOX5MAPTMEN1KMT2ATDP1
SCHEMBL19082463 0.92 ALOX5 (0.40) ALOX5MAPTHSD17B10ALDH1A1HPGD
SCHEMBL19081639 0.92 ALOX5 (0.40) ALOX5MAPTHSD17B10HPGDMEN1
SCHEMBL17944538 0.91 ALOX5 (0.49) ALOX5MAPTHSD17B10ALDH1A1HPGD
SCHEMBL17944506 0.91 ALOX5 (0.43) ALOX5MAPTHSD17B10ALDH1A1HPGD
SCHEMBL19081659 0.91 ALOX5 (0.36) ALOX5MAPTHSD17B10ALDH1A1HPGD
SCHEMBL22063331 0.90 ALOX5 (0.44) ALOX5MAPTHSD17B10ALDH1A1HPGD
SCHEMBL19109837 0.89 ALOX5 (0.45) ALOX5MAPTHSD17B10ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ALOX5 1939/4885MAPT 1294/4885HSD17B10 1824/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ALOX5 1939/4885MAPT 1294/4885HSD17B10 1824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.